Literature DB >> 26400220

Multiple chronic conditions and healthcare costs among adults.

Usha Sambamoorthi, Xi Tan1, Arijita Deb1.   

Abstract

The prevalence of multiple chronic conditions (MCC) is increasing among individuals of all ages. MCC are associated with poor health outcomes. The presence of MCC has profound healthcare utilization and cost implications for public and private insurance payers, individuals, and families. Investigators have used a variety of definitions for MCC to evaluate costs associated with MCC. The objective of this article is to examine the current literature in estimating excess costs associated with MCC among adults. The discussion highlights some of the theoretical and technical merits of various MCC definitions and models used to estimate the excess costs associated with MCC.

Entities:  

Keywords:  comorbidity; cost burden; expenditures; multimorbidity; multiple chronic conditions; out-of-pocket costs

Mesh:

Year:  2015        PMID: 26400220      PMCID: PMC4698815          DOI: 10.1586/14737167.2015.1091730

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  81 in total

1.  Estimating log models: to transform or not to transform?

Authors:  W G Manning; J Mullahy
Journal:  J Health Econ       Date:  2001-07       Impact factor: 3.883

2.  Costs associated with multimorbidity among VA patients.

Authors:  Jean Yoon; Donna Zulman; Jennifer Y Scott; Matthew L Maciejewski
Journal:  Med Care       Date:  2014-03       Impact factor: 2.983

3.  Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults.

Authors:  Rituparna Bhattacharya; Mayank Ajmera; Sandipan Bhattacharjee; Usha Sambamoorthi
Journal:  Diabetes Res Clin Pract       Date:  2014-06-04       Impact factor: 5.602

4.  Randomized controlled trials: do they have external validity for patients with multiple comorbidities?

Authors:  Martin Fortin; Jonathan Dionne; Geneviève Pinho; Julie Gignac; José Almirall; Lise Lapointe
Journal:  Ann Fam Med       Date:  2006 Mar-Apr       Impact factor: 5.166

5.  Estimating mean total costs in the presence of censoring: a comparative assessment of methods.

Authors:  Tracey A Young
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Prevalence of multiple chronic conditions in the United States' Medicare population.

Authors:  Kathleen M Schneider; Brian E O'Donnell; Debbie Dean
Journal:  Health Qual Life Outcomes       Date:  2009-09-08       Impact factor: 3.186

7.  Association of metformin use with cancer incidence and mortality: a meta-analysis.

Authors:  Pengpeng Zhang; Hao Li; Xianhua Tan; Lili Chen; Shumei Wang
Journal:  Cancer Epidemiol       Date:  2013-01-24       Impact factor: 2.984

8.  Total and out-of-pocket expenditures for prescription drugs among older persons.

Authors:  Usha Sambamoorthi; Dennis Shea; Stephen Crystal
Journal:  Gerontologist       Date:  2003-06

9.  Comorbidity and the use of primary care and specialist care in the elderly.

Authors:  Barbara Starfield; Klaus W Lemke; Robert Herbert; Wendy D Pavlovich; Gerard Anderson
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.707

10.  The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system.

Authors:  Raymond N Kuo; Mei-Shu Lai
Journal:  Int J Equity Health       Date:  2013-08-20
View more
  31 in total

1.  Engaging older adults as partners in transitional care research.

Authors:  Rebecca Ganann; Carrie McAiney; William Johnson
Journal:  CMAJ       Date:  2018-11-07       Impact factor: 8.262

2.  Physical therapists familiarity and beliefs about health services utilization and health seeking behaviour.

Authors:  Derek Clewley; Dan Rhon; Tim Flynn; Shane Koppenhaver; Chad Cook
Journal:  Braz J Phys Ther       Date:  2018-02-21       Impact factor: 3.377

3.  Costs of multimorbidity: a systematic review and meta-analyses.

Authors:  Phuong Bich Tran; Joseph Kazibwe; Georgios F Nikolaidis; Ismo Linnosmaa; Mieke Rijken; Josefien van Olmen
Journal:  BMC Med       Date:  2022-07-19       Impact factor: 11.150

4.  Effect of frailty on resource use and cost for Medicare patients.

Authors:  Kit N Simpson; Bryant A Seamon; Brittany N Hand; Courtney O Roldan; David J Taber; William P Moran; Annie N Simpson
Journal:  J Comp Eff Res       Date:  2018-05-29       Impact factor: 1.744

5.  Cellular senescence in intervertebral disc aging and degeneration.

Authors:  Prashanti Patil; Laura J Niedernhofer; Paul D Robbins; Joon Lee; Gwendolyn Sowa; Nam Vo
Journal:  Curr Mol Biol Rep       Date:  2018-10-25

6.  Universal Health Coverage: Are Older Adults Being Left Behind? Evidence From Aging Cohorts In Twenty-Three Countries.

Authors:  James Macinko; Flavia Cristina Drumond Andrade; Fabiola Bof de Andrade; Maria Fernanda Lima-Costa
Journal:  Health Aff (Millwood)       Date:  2020-11       Impact factor: 6.301

7.  Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US.

Authors:  Drishti Shah; Lindsay Allen; Wanhong Zheng; Suresh S Madhavan; Wenhui Wei; Traci J LeMasters; Usha Sambamoorthi
Journal:  Pharmacoeconomics       Date:  2021-04-27       Impact factor: 4.558

8.  Multimorbidity Burden in Rheumatoid Arthritis: A Population-based Cohort Study.

Authors:  Tina M Gunderson; Elena Myasoedova; John M Davis; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2021-02-15       Impact factor: 5.346

9.  Immune checkpoint inhibitor use, multimorbidity and healthcare expenditures among older adults with late-stage melanoma.

Authors:  Pragya Rai; Chan Shen; Joanna Kolodney; Kimberly M Kelly; Virginia G Scott; Usha Sambamoorthi
Journal:  Immunotherapy       Date:  2020-11-05       Impact factor: 4.196

10.  Age trends in 30 day hospital readmissions: US national retrospective analysis.

Authors:  Jay G Berry; James C Gay; Karen Joynt Maddox; Eric A Coleman; Emily M Bucholz; Margaret R O'Neill; Kevin Blaine; Matthew Hall
Journal:  BMJ       Date:  2018-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.